Pictet Asset Management Holding SA »

Cytokinetics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $110M 2.1M 52.78
2024-03-31 $123M 1.8M 70.20

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Cytokinetics

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Investment Management
State Street Corporation
Darwin Global Management
Bank of America Corporation
Armistice Capital
Geode Capital Management
T. Rowe Price Associates
Pentwater Capital Management
Boxer Capital
Pictet Asset Management Holding SA
Vestal Point Capital
Alliancebernstein

View all funds holding Cytokinetics